Medi Assist AI upgrades cut hospital pre-authorisations to under five minutes

2 min read     Updated on 04 Aug 2026, 03:51 PM
scanx
Reviewed by
Anirudha BScanX News Team
AI Summary

Medi Assist Healthcare Services Limited leveraged AI upgrades to approve over 50% of pre-authorisations in under five minutes. The initiative boosted NPS to 67 and cut claimant calls by over 60%. MAven IDP is now available to external insurers and providers.

powered bylight_fuzz_icon
47384443

*this image is generated using AI for illustrative purposes only.

Medi Assist Healthcare Services Limited has significantly accelerated its cashless healthcare processing capabilities, reporting that more than 50% of hospital pre-authorisations are now approved in under five minutes. The milestone follows major upgrades to its artificial intelligence platforms, specifically MAven Intelligent Document Processing (MAven IDP), MAGnum, and MAven Guard. These technological enhancements aim to reduce friction in patient admissions and strengthen claims integrity for insurers and healthcare providers across India.

The operational improvements have yielded measurable outcomes in customer satisfaction and efficiency. Medi Assist TPA, a wholly owned subsidiary of the company, recorded a Net Promoter Score (NPS) of 67, reflecting gains in speed and consistency. Additionally, calls from claimants dropped by over 60%, indicating a smoother claims journey with fewer manual interventions required.

Satish Gidugu, CEO of Medi Assist Group, stated that the company’s strategy focuses on simplifying the entire cashless journey, from admission to fraud detection. He noted that each platform upgrade removes points of friction between patients and necessary care, extending the approach previously used in the discharge process with Raksha Prime.

Platform Enhancements

The upgrades target distinct stages of the healthcare administration workflow:

Platform Function Impact
MAven IDP AI-enabled document processing Standardises hospitalisation documents into structured clinical summaries for faster decisions
MAGnum Real-time hospital transparency Allows hospitals to track claim status and Raksha Prime eligibility in real time
MAven Guard Fraud detection Detects fraud, waste, and abuse with up to 50% greater precision

MAven IDP reads and standardises hospitalisation documents, providing claims teams with structured clinical summaries. This enables faster and more consistent decision-making, allowing patients to be admitted sooner. Meanwhile, MAGnum provides hospitals with real-time visibility into whether a patient qualifies for Raksha Prime, the status of every claim, and which cases have been settled and paid. This transparency reduces queries and facilitates faster admissions.

MAven Guard’s latest release enhances claims integrity by detecting fraud, waste, and abuse with up to 50% greater precision. This protects the ecosystem while ensuring genuine claims are processed without delay.

What the Numbers Show

The reduction in claimant calls by over 60% alongside an NPS of 67 suggests that automation is effectively resolving issues before they require human intervention. The ability to approve more than 50% of pre-authorisations in under five minutes indicates a shift from manual, document-heavy processes to automated, data-driven approvals, directly impacting patient wait times and hospital operational efficiency.

In a significant expansion, MAven IDP is now available to insurers and healthcare providers beyond the Medi Assist Group, extending its impact to the broader healthcare ecosystem in India.

Historical Stock Returns for Medi Assist Healthcare

1 Day5 Days1 Month6 Months1 Year5 Years
-0.91%+3.04%-4.54%-13.14%-33.74%-22.93%

How might the external availability of MAven IDP to third-party insurers impact Medi Assist's competitive positioning and revenue diversification strategies?

What are the potential regulatory or data privacy challenges associated with expanding AI-driven fraud detection and document processing across India's broader healthcare ecosystem?

Could the significant reduction in manual claimant calls lead to workforce restructuring within Medi Assist, and how will the company address potential employee displacement?

like18
dislike

Medi Assist Q1 Results: Board meets Aug 8 to approve financials

1 min read     Updated on 03 Aug 2026, 06:19 PM
scanx
Reviewed by
Jubin VScanX News Team
AI Summary

Medi Assist Healthcare Services Limited will approve its Q1FY27 financial results on August 8, 2026. An earnings call featuring Dr. Vikram Chhatwal, Satish Gidugu, and Sandeep Daga is set for August 10, 2026. The insider trading window remains closed until 48 hours post-declaration.

powered bylight_fuzz_icon
47306973

*this image is generated using AI for illustrative purposes only.

Medi Assist Healthcare Services Limited will declare its unaudited standalone and consolidated financial results for the first quarter of FY27 on August 8, 2026. The Board of Directors is scheduled to meet on Saturday, August 8, 2026, to consider and approve these figures, which cover the period ended June 30, 2026. Investors seeking details on the company’s performance will have the opportunity to engage with management during an earnings call scheduled for Monday, August 10, 2026, at 08:30 am IST.

The disclosure is made pursuant to Regulation 29(1) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company notified both the National Stock Exchange of India Limited and BSE Limited of the upcoming meeting. This procedural step ensures transparency in the reporting timeline for shareholders and regulatory bodies.

Under the SEBI (Prohibition of Insider Trading) Regulations, 2015, the trading window for Designated Persons and their immediate relatives remains closed. The window was shut on July 1, 2026, and will stay closed until 48 hours after the declaration of the financial results. This restriction prevents insider trading during the sensitive pre-announcement period.

Earnings Call Details

Management will host an earnings call to discuss the Q1FY27 results on August 10, 2026. The session will provide insights into the financial performance and operational updates. Participants are advised to register in advance to avoid waiting times.

Participant Designation
Dr. Vikram Chhatwal Chairman and Whole-time Director
Satish Gidugu Chief Executive Officer and Whole-time Director
Sandeep Daga Chief Financial Officer

Participants can register via the provided link to receive dial-in numbers, passcodes, and PINs. Universal dial-in numbers are available for India, with international toll-free numbers provided for the UK, USA, Singapore, and Hong Kong. For further inquiries, investors may contact investor.relations@mediassist.in .

What the Numbers Show

While specific financial metrics such as revenue or net profit are not yet disclosed, the timing of the announcement aligns with standard quarterly reporting cycles for Indian listed entities. The focus for investors will be on the growth trajectory of the healthcare services sector and Medi Assist’s market share dynamics, which will be elaborated upon during the management discussion on August 10.

Historical Stock Returns for Medi Assist Healthcare

1 Day5 Days1 Month6 Months1 Year5 Years
-0.91%+3.04%-4.54%-13.14%-33.74%-22.93%

How might Medi Assist's Q1FY27 performance reflect broader trends in India's healthcare services sector amid changing regulatory landscapes?

What specific operational metrics or growth initiatives will management highlight during the August 10 earnings call to justify future valuation multiples?

Could the upcoming results signal any strategic shifts in Medi Assist's market share dynamics against key competitors in the health insurance and services space?

like15
dislike

More News on Medi Assist Healthcare

1 Year Returns:-33.74%